ANTI-ATHEROMA IMPSTOFF

European patent · EP2281007 · In force

Register entry

Publication number
EP2281007
Application number
EP09730769
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 14, 2009
Published
Feb 9, 2011
Granted
Jul 9, 2014
Protection ends at the latest
Apr 13, 2029
Next annual fee due
Apr 30, 2027
IPC classes
C07K 19/00 (2006.01)
C12N 15/62 (2006.01)
A61K 39/385 (2006.01)
A61K 48/00 (2006.01)
A61P 9/10 (2006.01)
Priority
GB 0806461 10.04.2008
GB 0807579 25.04.2008
PCT application
PCT/GB2009/050366 14.04.2009
PCT publication
WO2009/125231 15.10.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 11, 2026

    Change

    Published in Swissreg on 11.05.2026

  2. May 2, 2025

    Change

    Published in Swissreg on 02.05.2025

  3. May 8, 2024

    Change

    Published in Swissreg on 08.05.2024

  4. May 8, 2023

    Change

    Published in Swissreg on 08.05.2023

  5. Oct 10, 2014

    Agent entered

    Representative
    Meyer & Kollegen, Ringstrasse 35c, 7000 Chur

    Published in Swissreg on 10.10.2014

  6. Jul 9, 2014

    Granted

    Published in Swissreg on 09.07.2014

Parties

Holder

Thrombosis Research Institute

90 Fetter Lane, London, Greater London EC4A 1PT, GB

Agent

Meyer & Kollegen

Ringstrasse 35c, 7000 Chur

Inventor

KAKKAR, Vijay

Greater London EC4A 1PT, GB

LU, Xinjie

Greater London EC4A 1PT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.